HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi).

AuthorsKate L Burbury, Mark J Bishton, Ricky W Johnstone, Michael J Dickinson, Jeffrey Szer, H Miles Prince
JournalAnnals of hematology (Ann Hematol) Vol. 90 Issue 7 Pg. 847-9 (Jul 2011) ISSN: 1432-0584 [Electronic] Germany
PMID20949272 (Publication Type: Case Reports, Letter)
Chemical References
  • Histone Deacetylase Inhibitors
  • Myeloid-Lymphoid Leukemia Protein
Topics
  • Adult
  • Histone Deacetylase Inhibitors (therapeutic use)
  • Humans
  • Leukemia (drug therapy, genetics, pathology, physiopathology)
  • Male
  • Middle Aged
  • Myeloid-Lymphoid Leukemia Protein (genetics)
  • Remission Induction
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: